There are a broad range of investment vehicles available to life sciences innovators, to move their work from concept to the market. This presentation will provide a compact overview of such options, including seed and growth funds, general characteristics of each, as well as evolving investment landscape. There is also a discussion around current state of the public market, how it is impacting availability of capital for investment and M&A in the early stage companies.
The event will wrap-up with Q&A.
Mostafa Analoui, Ph.D., Executive Director of Venture Development and Technology Incubation Program (TIP) UConn; BioCT Director
Mostafa is Executive Director of Venture Development and Technology Incubation Program (TIP) at UConn. Previously, he was Head of Healthcare and Life Sciences at Livingston Securities (New York, NY) with investment focus in private and public companies in biotech, medtech and healthcare services. Prior to that, he was the Senior Director at Pfizer Global Research and Development. Dr. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies.
While at Pfizer, he was the Site Head for Global Clinical Technology in Groton and New London, a division focusing on emerging technologies for development and validation of biomarkers and diagnostics for drug development. Prior to joining Pfizer, Dr. Analoui was the Director of Oral and Maxillofacial Imaging Research, Associate Professor of Radiology at Indiana University, and Associate Professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc. He has received his Ph.D. from Purdue University, followed by Post-Doctoral Fellowship at IBM TJ Watson Research Center in NY.